Company Search:
Advanced Search
Sponsored Links
Agenus Incorporation Company Snapshot
Agenus Incorporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Agenus Incorporation with three other companies in this sector in the United States: Neurocrine Biosciences Inc (2015 sales of $19.77 million of which 100% was Therapeutics), Vical Incorporated ($20.95 million of which 100% was Biopharmaceutical), and Aviragen Therapeutics Inc ($24.60 million of which 100% was Antibody Products).

Sales Analysis. Sales increased substantially in 2015: During the year ended December of 2015, sales at Agenus Incorporation were $24.82 million. This is an increase of 255.7% versus 2014, when the company's sales were $6.98 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Agenus Incorporation
  Stock Performance Chart for Agenus Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 4.51
(Figures in U.S. Dollars)
1 Week 10.3%   13 Weeks 19.6%  
4 Weeks -8.3%   52 Weeks 50.3%  
Agenus Incorporation Key Data:
  Ticker: AGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 24,817,025
(Year Ending Jan 2016).
Employees: 53
  Currency: U.S. Dollars Market Cap: 392,891,013
  Fiscal Yr Ends: December Shares Outstanding: 87,115,524
  Share Type: Common Closely Held Shares: 5,027,042
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.